(600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
Filed with SSE · Stock code 600351 · · 2 pages · Chinese
Summary by 6ix AI
Yabao Pharmaceutical Group Co. Ltd. has announced progress on its share repurchase plan through a call auction. The repurchase is part of a plan approved by the board to enhance shareholder value and reduce registered capital.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Yabao Pharmaceutical Group Co. Ltd. on 6ix
Story so far
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Use of Idle Self-owned Funds for Entrusted Wealth Management
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 3rd Meeting of the 10th Board of Directors
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Stock Collateralized Repo Trading by Controlling Shareholder
Earlier from Yabao Pharmaceutical
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Report for Q3 2026
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Use of Idle Self-owned Funds for Entrusted Wealth Management
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Stock Collateralized Repo Trading by Controlling Shareholder
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 3rd Meeting of the 10th Board of Directors
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Progress of Capital Reduction of a Controlled Subsidiary Following the Conversion of Capital Reserve into Registered Capital and Completion of Industrial and Commercial Registration Changes
Follow Yabao Pharmaceutical into a list and get an email when it puts out news.
Follow Yabao Pharmaceutical